Healthcare • Biotechnology
EODHD (TTM) · as of Oct 13, 2026
End-of-day close from stored market data, not a live quote.
Sign in to see your position size
We’ll show you if ALDX is in your portfolio and how much it contributes.
Sign inLoading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
24 top institutions tracked
Last 13F trend: unchanged (light)
Unlock crowding heatmapUnlock filer discoverySentiment: unknown
No recent insider trades detected.
Red flags: 0
108 filers reported a long position in ALDX for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| Knoll Capital Management, LLC | $11.7M | 5.5M | Unchanged |
| AQR CAPITAL MANAGEMENT LLC | $8M | 3.8M | +32.6% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | $5.6M | 2.7M | +23.2% |
| VANGUARD CAPITAL MANAGEMENT LLC | $5M | 2.4M | -0.1% |
| D. E. Shaw & Co., Inc. | $4.1M | 1.9M | +38.2% |
| MARSHALL WACE, LLP | $3.2M | 1.5M | +1,062% |
| 683 Capital Management, LLC | $3.1M | 1.5M | -3.3% |
| JANE STREET GROUP, LLC | $2.9M | 1.4M | +41.9% |
| BlackRock, Inc. | $2.7M | 1.3M | -66.6% |
| Qube Research & Technologies Ltd | $2.4M | 1.1M | +1,196.3% |
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.